Metapathway biotransformation Phase I and II

Pathway network for the Metapathway biotransformation Phase I and II SuperPath

Sources:
  • WikiPathways
  • Reactome
  • GeneGo (Thomson Reuters)
  • PharmGKB

Pathways in the Metapathway biotransformation Phase I and II SuperPath

#NameSourceGenes
1Metapathway biotransformation Phase I and IIWikiPathways
2Biological oxidationsReactome
3Phase I - Functionalization of compoundsReactome
4Phase II - Conjugation of compoundsReactome
5Cytochrome P450 - arranged by substrate typeReactome
6Oxidation by cytochrome P450WikiPathways
7Endogenous sterolsReactome
8XenobioticsReactome
9Estradiol metabolismGeneGo (Thomson Reuters)
10Cytosolic sulfonation of small moleculesReactome
11Tamoxifen Pathway, PharmacokineticsPharmGKB
12Acetaminophen metabolismGeneGo (Thomson Reuters)
13Fatty acid omega-oxidationWikiPathways
14Fatty acidsReactome
15MethylationReactome
16Benzo[a]pyrene metabolismGeneGo (Thomson Reuters)
17EicosanoidsReactome
18Ethanol oxidationReactome
19Miscellaneous substratesReactome
20Benzodiazepine Pathway, PharmacokineticsPharmGKB
21Haloperidol Pathway, PharmacokineticsPharmGKB
22Cannabidiol Pathway, PharmacokineticsPharmGKB
23CYP2E1 reactionsReactome
24Benzo(a)pyrene metabolismWikiPathways
25Arylamine metabolismWikiPathways
26Lidocaine Pathway, PharmacokineticsPharmGKB
27Cyclophosphamide Pathway, PharmacokineticsPharmGKB
28Voriconazole Pathway, PharmacokineticsPharmGKB
29Aflatoxin B1 metabolismWikiPathways
30Naproxen Pathway, PharmacokineticsPharmGKB
31Fluvoxamine Pathway, PharmacokineticsPharmGKB
32Aryl hydrocarbon receptor signallingReactome
33In progress: Buprenorphine Pathway, PharmacokineticsPharmGKB
34Sorafenib PharmacokineticsPharmGKB
35Vitamin D2 (ergocalciferol) metabolismGeneGo (Thomson Reuters)
36Prasugrel Pathway, PharmacokineticsPharmGKB
37Atomoxetine Pathway, PharmacokineticsPharmGKB
38VitaminsReactome
39Toremifene Pathway, PharmacokineticsPharmGKB
40Artemisinin and Derivatives Pathway, PharmacokineticsPharmGKB
41Ospemifene Pathway, PharmacokineticsPharmGKB
42Belinostat Pathway, PharmacokineticsPharmGKB
43Fluoxetine Pathway, PharmacokineticsPharmGKB
44Ketamine Pathway, PharmacokineticsPharmGKB
45Celecoxib Pathway, PharmacokineticsPharmGKB
46Amine Oxidase reactionsReactome
47Trimipramine Pathway, PharmacokineticsPharmGKB
48Trazodone Pathway, PharmacokineticsPharmGKB
49Flurbiprofen Pathway, PharmacokineticsPharmGKB
50Disulfiram Pathway, PharmacokineticsPharmGKB
51Letrozole Pathway, PharmacokineticsPharmGKB
52Cilostazol Pathway, PharmacokineticsPharmGKB
53Hydralazine Pathway, PharmacokineticsPharmGKB
54Phenprocoumon Pathway, PharmacokineticsPharmGKB
55AcetylationReactome
56Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOBReactome
57Defective CYP27A1 causes CTXReactome
58Sterols are 12-hydroxylated by CYP8B1Reactome
59Defective MAOA causes BRUNSReactome
60Defective CYP26C1 causes FFDD4Reactome
61Defective CYP4F22 causes ARCI5Reactome
62Defective CYP27B1 causes VDDR1BReactome
63Defective CYP24A1 causes HCAIReactome
64Defective CYP26B1 causes RHFCAReactome
65Defective TPMT causes TPMT deficiencyReactome
66Defective CYP27B1 causes VDDR1AReactome

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Metapathway biotransformation Phase I and II SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Cerebrotendinous xanthomatosisDirect
2Disease of mental healthDirect
3Skin benign neoplasmDirect
4Autosomal recessive congenital ichthyosisDirect
5RicketsDirect
6HypercalcemiaDirect
7CraniosynostosisDirect
8Inherited metabolic disorderDirect
9Gilbert syndromeEnrichmentUGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A916.00
10Crigler-najjar syndrome, type iEnrichmentUGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A916.00
11Hyperbilirubinemia, transient familial neonatalEnrichmentUGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A916.00
12Bilirubin, serum level of, quantitative trait locus 1EnrichmentUGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A916.00
13Crigler-najjar syndrome, type iiEnrichmentUGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A916.00
14Bilirubin metabolic disorderEnrichmentUGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A916.00
15Alcohol dependenceEnrichmentADH1B, ADH1C, ALDH27.97
16Coumarin resistanceEnrichmentCYP2A6, CYP2C96.49
17Lipoid congenital adrenal hyperplasiaEnrichmentCYP11A1, CYP11B1, CYP17A1, POR6.45
18Vitamin d hydroxylation-deficient rickets, type 1aEnrichmentCYP27B1, CYP2R16.31
19Amed syndrome, digenicEnrichmentADH5, ALDH26.14
2046,xy sex reversal 8EnrichmentAKR1C2, AKR1C45.93
21Homocystinuria-megaloblastic anemia, cblg typeEnrichmentMTR, MTRR5.53
22Neural tube defects, folate-sensitiveEnrichmentMTR, MTRR5.23
23Hereditary methemoglobinemiaEnrichmentCYB5A, CYB5R34.70
24Pulmonary disease, chronic obstructiveEnrichmentCYP2R1, CYP46A1, MGST1, MGST34.67
25Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiencyEnrichmentCYP11A1, CYP17A1, CYP21A24.32
2621-hydroxylase-deficient congenital adrenal hyperplasiaEnrichmentCYP11A1, CYP17A1, CYP21A24.32
27Hyperaldosteronism, familial, type iEnrichmentCYP11B1, CYP11B24.28
28Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiencyEnrichmentCYB5A, CYP17A14.23
29Acetylation, slowEnrichmentNAT23.83
30Brunner syndromeEnrichmentMAOA3.83
31Drug metabolism, poor, cyp2c19-relatedEnrichmentCYP2C193.66
32Drug metabolism, poor, cyp2d6-relatedEnrichmentCYP2D63.66
33Vitamin d-dependent rickets, type 3EnrichmentCYP3A43.66
34Thiopurines, poor metabolism of, 1EnrichmentTPMT3.66
35Anemia, congenital, nonspherocytic hemolytic, 10EnrichmentGSR3.66
36Letrozole toxicityEnrichmentCYP2A63.66
37Drug metabolism, altered, cyp2c8-relatedEnrichmentCYP2C83.66
38Efavirenz, poor metabolism ofEnrichmentCYP2B63.43
39Radiohumeral fusions with other skeletal and craniofacial anomaliesEnrichmentCYP26B13.35
40Focal facial dermal dysplasia 4EnrichmentCYP26C13.35
41Lethal occipital encephalocele-skeletal dysplasia syndromeEnrichmentCYP26B13.35
42Drug metabolism, altered, ces1-relatedEnrichmentCES13.29
43Severe primary trimethylaminuriaEnrichmentFMO33.29
44Genetic lipodystrophyEnrichmentEPHX13.29
45Retinitis pigmentosa 85EnrichmentAHR3.29
46Foveal hypoplasia 3EnrichmentAHR3.29
47Webb-dattani syndromeEnrichmentARNT23.29
48Megalencephalic leukoencephalopathy with subcortical cysts 1EnrichmentGSTT2, GSTT2B3.23
49Tobacco addictionEnrichmentCYP2A63.05
50Vitamin d hydroxylation-deficient rickets, type 1bEnrichmentCYP2R13.05
51Hypercalcemia, infantile, 1EnrichmentCYP24A13.05
52Autosomal recessive infantile hypercalcemiaEnrichmentCYP24A13.05
53Ghosal hematodiaphyseal dysplasiaEnrichmentTBXAS13.05
54Ichthyosis, congenital, autosomal recessive 5EnrichmentCYP4F223.05
55Alcohol sensitivity, acuteEnrichmentALDH23.05
56TrimethylaminuriaEnrichmentFMO32.99
57Primary trimethylaminuriaEnrichmentFMO32.99
58AcromegalyEnrichmentAIP2.99
59Null pituitary adenomaEnrichmentAIP2.99
60Familial isolated pituitary adenomaEnrichmentAIP2.99
61Silent pituitary adenomaEnrichmentAIP2.99
62GigantismEnrichmentAIP2.99
63Hypermethioninemia with s-adenosylhomocysteine hydrolase deficiencyEnrichmentAHCY2.99
64Catechol-o-methyltransferase activity, variation inEnrichmentCOMT2.99
65Homocystinuria without methylmalonic aciduriaEnrichmentMTRR2.99
66Glaucoma 1, open angle, aEnrichmentCYP1B12.88
67Anterior segment dysgenesis 6EnrichmentCYP1B12.88
68Cic-rearranged sarcomaEnrichmentAKR1C22.88
69Primary congenital glaucomaEnrichmentCYP1B12.88
70Chondrodysplasia with joint dislocations, gpapp typeEnrichmentBPNT22.88
71Ichthyosis, congenital, autosomal recessive 14EnrichmentSULT2B12.88
72Pituitary adenoma 1, multiple typesEnrichmentAIP2.81
73Growth hormone secreting pituitary adenomaEnrichmentAIP2.81
74Aip familial isolated pituitary adenomasEnrichmentAIP2.81
75Kala-azar 2EnrichmentGSTP12.75
76Bleeding disorder, platelet-type, 14EnrichmentTBXAS12.75
77Adrenal insufficiency, congenital, with 46,xy sex reversal, partial or completeEnrichmentCYP11A12.72
78Bile acid synthesis defect, congenital, 3EnrichmentCYP7B12.72
79Cholestasis, progressive familial intrahepatic, 5EnrichmentNR1H42.72
80Congenital cataract-severe neonatal hepatopathy-global developmental delay syndromeEnrichmentCYP51A12.72
81Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiencyEnrichmentCYP7A12.72
82Inherited isolated adrenal insufficiency due to partial cyp11a1 deficiencyEnrichmentCYP11A12.72
83Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndromeEnrichmentFDXR2.72
84Parkinson disease, mitochondrialEnrichmentADH1C2.69
85ProlactinomaEnrichmentAIP2.69
86Homocystinuria-megaloblastic anemia, cble typeEnrichmentMTRR2.69
87Methionine adenosyltransferase i/iii deficiencyEnrichmentMAT1A2.69
88Disorders of intracellular cobalamin metabolismEnrichmentMTR2.69
89Methionine adenosyltransferase deficiencyEnrichmentMAT1A2.69
90Primary ovarian insufficiencyEnrichmentCYP17A1, CYP19A1, POR2.63
91Familial hypercholanemiaEnrichmentBAAT, EPHX12.58
92Glaucoma 3, primary infantile, bEnrichmentCYP1B12.58
93Hereditary spastic paraplegia 56EnrichmentCYP2U12.58
94Spastic paraplegia 56, autosomal recessive, with or without pseudoxanthoma elasticumEnrichmentCYP2U12.58
95Hypertension, essentialEnrichmentCYP3A5, PTGIS2.52
96HomocystinuriaEnrichmentMTR2.51
97Juvenile glaucomaEnrichmentCYP1B12.48
98Corticosterone methyloxidase type i deficiencyEnrichmentCYP11B22.42
99Corticosterone methyloxidase type ii deficiencyEnrichmentCYP11B22.42
100Spastic paraplegia 5a, autosomal recessiveEnrichmentCYP7B12.42
101Familial hypoaldosteronismEnrichmentCYP11B22.42
102Early-onset familial hypoaldosteronismEnrichmentCYP11B22.42
103Glaucoma, primary open angleEnrichmentCYP1B12.40
104Developmental dysplasia of the hip 1EnrichmentAKR1C12.40
105Anterior segment dysgenesis 5EnrichmentCYP1B12.40
106Ichthyosis, congenital, autosomal recessive 1EnrichmentSULT2B12.40
107Down syndromeEnrichmentMTRR2.38
108Brachycephaly, deafness, cataract, microstomia, and impaired intellectual developmentEnrichmentPOR2.35
109Glaucoma 3, primary congenital, aEnrichmentCYP1B12.33
110Adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiencyEnrichmentCYP11B12.24
111Mitochondrial myopathy, episodic, with or without optic atrophy and reversible leukoencephalopathyEnrichmentFDX22.24
112Bietti crystalline corneoretinal dystrophyEnrichmentCYP4V22.24
113Obesity, early-onset, with adrenal insufficiency and red hairEnrichmentPOMC2.24
114Aromatase excess syndromeEnrichmentCYP19A12.24
115Auditory neuropathy and optic atrophyEnrichmentFDXR2.24
116Multiple mitochondrial dysfunctions syndrome 9bEnrichmentFDXR2.24
117Aromatase deficiencyEnrichmentCYP19A12.24
118Deficiency of steroid 11-beta-monooxygenaseEnrichmentCYP11B12.24
119Obesity due to pro-opiomelanocortin deficiencyEnrichmentPOMC2.24
120Septooptic dysplasiaEnrichmentARNT22.21
121Multiple sclerosisEnrichmentCYP27B12.21
122Peters-plus syndromeEnrichmentCYP1B12.18
123Ichthyosis, congenital, autosomal recessive 2EnrichmentSULT2B12.18
124Lung cancerEnrichmentCYP2A62.15
125ChoroideremiaEnrichmentCYP4V22.12
126Intrahepatic cholestasis of pregnancyEnrichmentNR1H42.12
127Glutathione synthetase deficiencyEnrichmentGSS2.11
128Bone mineral density quantitative trait locus 12EnrichmentUGT2B172.11
129GlutathionuriaEnrichmentGGT12.11
130Anemia, congenital, nonspherocytic hemolytic, 6EnrichmentGSS2.11
131Anemia, congenital, nonspherocytic hemolytic, 7EnrichmentGCLC2.11
1325-oxoprolinase deficiencyEnrichmentOPLAH2.11
133Developmental and epileptic encephalopathy 84EnrichmentUGDH2.11
134Maleylacetoacetate isomerase deficiencyEnrichmentGSTZ12.11
135Developmental and epileptic encephalopathy 83EnrichmentUGP22.11
136Orofacial cleft 1EnrichmentACSS22.10
137Methemoglobinemia and ambiguous genitaliaEnrichmentCYB5A2.05
138Antley-bixler syndrome with genital anomalies and disordered steroidogenesisEnrichmentPOR2.05
139Methemoglobinemia due to deficiency of methemoglobin reductaseEnrichmentCYB5R32.05
140Antley-bixler syndrome without genital anomalies or disordered steroidogenesisEnrichmentPOR2.05
141Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiencyEnrichmentPOR2.05
142Cytochrome p450 oxidoreductase deficiencyEnrichmentPOR2.05
143Anterior segment dysgenesisEnrichmentCYP1B12.00
144Cholestasis, progressive familial intrahepatic, 1EnrichmentNR1H41.94
145Digeorge syndromeEnrichmentCOMT1.91
146Parkinson disease, late-onsetEnrichmentADH1C1.91
147Myocardial infarctionEnrichmentGCLC, GCLM1.91
148Congenital nonbullous ichthyosiform erythrodermaEnrichmentSULT2B11.88
149Macular dystrophy, cornealEnrichmentCHST61.87
150Bile acid synthesis defect, congenital, 2EnrichmentAKR1D11.87
151Spondylometaphyseal dysplasia, sedaghatian typeEnrichmentGPX41.87
152Intellectual developmental disorder, autosomal recessive 51EnrichmentHNMT1.87
153Neurofacioskeletal syndrome with or without renal agenesisEnrichmentHS2ST11.87
154Intellectual developmental disorder, autosomal recessive 46EnrichmentNDST11.87
155Angioedema, hereditary, 8EnrichmentHS3ST61.87
156Paganini-miozzo syndromeEnrichmentHS6ST21.87
157Intellectual developmental disorder, autosomal recessive 73EnrichmentNAA201.87
158Osteochondrodysplasia, brachydactyly, and overlapping malformed digitsEnrichmentCHST111.87
159Hypogonadotropic hypogonadism 15 with or without anosmiaEnrichmentHS6ST11.87
160N-acetylaspartate deficiencyEnrichmentNAT8L1.87
161ArteriosclerosisEnrichmentHS3ST11.87
162Hypercholanemia, familial 3EnrichmentBAAT1.87
163Cystic fibrosisEnrichmentEPHX1, GCLC, GSTM31.85
164Hereditary spastic paraplegiaEnrichmentCYP2U1, CYP7B11.82
165Schneckenbecken dysplasiaEnrichmentSLC35D11.81
166Congenital myopathy 1a, autosomal dominant, with malignant hyperthermiaEnrichmentCYB5R31.75
167Congenital myopathy 1aEnrichmentCYB5R31.75
168Mitochondrial myopathyEnrichmentFDX21.68
169Cortical dysplasia, complex, with other brain malformations 5EnrichmentBPHL1.63
170Ehlers-danlos syndrome, musculocontractural type, 1EnrichmentCHST141.57
171Congenital bile acid synthesis defectEnrichmentAKR1D11.57
172Auroneurodental syndromeEnrichmentNAA801.57
173Larsen syndromeEnrichmentCHST31.40
174Multiple joint dislocations, short stature, and craniofacial dysmorphism with or without congenital heart defectsEnrichmentCHST31.40
175Larsen-like syndrome b3gat3 typeEnrichmentCHST31.40
176Musculocontractural ehlers-danlos syndromeEnrichmentCHST141.40
177EpilepsyEnrichmentMTR1.39
178Bardet-biedl syndromeEnrichmentCOMT1.37
179Autosomal recessive non-syndromic intellectual disabilityEnrichmentHNMT, NAA20, NDST11.36
180Familial thoracic aortic aneurysm and aortic dissectionEnrichmentMAT2A1.35
181KeratoconusEnrichmentALDH3A11.34
182Auditory neuropathyEnrichmentFDXR1.31
183Peeling skin syndrome 3EnrichmentCHST81.27
184Coronary artery anomalyEnrichmentHS3ST11.27
185Hereditary angioedema with normal c1inh not related to f12 or plg variantEnrichmentHS3ST61.27
186SchizophreniaEnrichmentCOMT1.23
187Retinitis pigmentosaEnrichmentAHR, CYP4V21.21
188Aminoacylase 1 deficiencyEnrichmentACY11.20
189Inherited cancer-predisposing syndromeEnrichmentAIP1.18
190Spondyloepiphyseal dysplasia with congenital joint dislocationsEnrichmentCHST31.10
191Optic atrophy plus syndromeEnrichmentCYP4V21.09
192Congenital nervous system abnormalityEnrichmentCYP2U11.05
193Nervous system diseaseEnrichmentCYP2U11.05
194Body mass index quantitative trait locus 11EnrichmentPOMC1.04
195Spastic ataxiaEnrichmentCYP7B11.01
196Myeloma, multipleEnrichmentRXRA0.99
197AsthmaEnrichmentHNMT0.86
198Hypercholesterolemia, familial, 1EnrichmentEPHX20.79
199Chromosome 1p36 deletion syndromeEnrichmentKCNAB20.79
200Familial hypercholesterolemiaEnrichmentEPHX20.73
201Normosmic congenital hypogonadotropic hypogonadismEnrichmentHS6ST10.66
202Kallmann syndromeEnrichmentHS6ST10.57
203Breast cancerEnrichmentCYP17A10.54
204West syndromeEnrichmentUGDH0.54
205Hereditary breast carcinomaEnrichmentNQO20.53
206Hereditary retinal dystrophyEnrichmentCYP4V20.37
207Fundus dystrophyEnrichmentCYP4V20.37
208Complex neurodevelopmental disorderEnrichmentHS2ST10.09

Loading...
Loading...
Loading...